Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer CenterGhassan Al Darazi, Thomas Filleron, Jean‐Pierre Delord et al.|International Journal of Cancer|2020Cited by 17